Your browser doesn't support javascript.
loading
Evaluation of the effects of the weak CYP3A inhibitors atorvastatin and ethinyl estradiol/norgestimate on lomitapide pharmacokinetics in healthy subjects.
Patel, Gina; King, Alex; Dutta, Santanu; Korb, Sarah; Wade, Janet R; Foulds, Pamela; Sumeray, Mark.
Affiliation
  • Patel G; Covance Early Clinical Biometrics, Madison, WI, USA.
  • King A; Covance Clinical Research Unit, Inc., Dallas, TX, USA.
  • Dutta S; Covance Early Clinical Biometrics, Madison, WI, USA.
  • Korb S; Covance Early Clinical Biometrics, Madison, WI, USA.
  • Wade JR; SGS Exprimo NV, Mechelen, Belgium.
  • Foulds P; Aegerion Pharmaceuticals, Inc., Cambridge, MA, USA.
  • Sumeray M; Aegerion Pharmaceuticals, Inc., Cambridge, MA, USA.
J Clin Pharmacol ; 56(1): 47-55, 2016 Jan.
Article in En | MEDLINE | ID: mdl-26120010

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzimidazoles / Cytochrome P-450 CYP3A Inhibitors / Anticholesteremic Agents Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pharmacol Year: 2016 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzimidazoles / Cytochrome P-450 CYP3A Inhibitors / Anticholesteremic Agents Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pharmacol Year: 2016 Document type: Article Affiliation country: United States Country of publication: United kingdom